Review
Cyclosporine-A as prevention for graft-versus-host disease in pediatric patients undergoing bone marrow transplants
- PMID: 2405360
Item in Clipboard
Review
Cyclosporine-A as prevention for graft-versus-host disease in pediatric patients undergoing bone marrow transplants
Oncol Nurs Forum.
1990 Jan-Feb.
Abstract
Cyclosporine-A is a drug commonly used in bone marrow transplantation (BMT) for the prevention of graft-versus-host disease. In the pediatric allogeneic BMT population at The Children's Hospital in Boston, a combination of Cyclosporine-A and Methotrexate is used for graft-versus-host prophylaxis. Graft-versus-host disease, whether acute or chronic, may be fatal. The increasing use of Cyclosporine-A in the pediatric BMT setting demands careful nursing assessment and intervention for Cyclosporine-A toxicity and related side effects.
Similar articles
-
Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias.Bone Marrow Transplant. 1989 Dec;4 Suppl 3:95-6. Bone Marrow Transplant. 1989. PMID: 2697416 Clinical Trial. No abstract available.
-
Decreased incidence of graft-versus-host disease in bone marrow transplantation recipients treated with a combination of cyclosporine and methotrexate.Transplant Proc. 1988 Jun;20(3):494-8. Transplant Proc. 1988. PMID: 3381257 No abstract available.
-
Methylprednisolone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host disease.Bone Marrow Transplant. 1990 Apr;5(4):269-72. Bone Marrow Transplant. 1990. PMID: 2337738
-
Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.Clin Pharm. 1993 Oct;12(10):736-61. Clin Pharm. 1993. PMID: 8258255 Review.
-
Canine models of bone marrow transplantation.Lab Anim Sci. 1990 Jan;40(1):11-5. Lab Anim Sci. 1990. PMID: 2153851 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical